In this report: Merge Healthcare (NASDAQ:MRGE), Onyx Pharmaceuticals (NASDAQ:ONXX), Research in Motion (NASDAQ:RIMM) and Potash (NYSE:POT).
Merge Healthcare (NASDAQ:MRGE) is trading over 14 percent higher today after the company announced that it will launch its new cloud based platform during the first quarter of 2012. Merge Healthcare unveiled its Merge Honeycomb image sharing product during a conference for Radiological Society of North America. The company last traded at $5.05 per share.
Onyx Pharmaceuticals (NASDAQ:ONXX) rallied 15 percent higher on Monday on reports from Bloomberg News that the company is in the early stages of exploring strategic options which could include a sale. One source with knowledge of the matter said that the cancer drug developer already has potential buyers who are studying Onyx’s business and its carfilzomib cancer therapy. Onyx Pharmaceuticals currently trades at $43.36 per share.
Research in Motion (NASDAQ:RIMM) is trading over 2.4 percent higher today despite receiving a downgrade by analysts at Stern Agee. The firm dropped its rating on the Blackberry maker to ‘Neutral’ from ‘Buy’ but that did not stop the company’s stock from increasing to its current price of $16.39 per share.
Potash (NYSE:POT) also rallied but this time due to an upgrade. The company seen its rating at Scotia upped to ‘Outperform’ from ‘Sector Perform’ which helped push the agricultural chemicals maker to its current price of $42.04 per share.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL